Two Sigma Advisers’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Two Sigma Advisers’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,000	Closed	-$206K	–	2789
2022 Q4	$206K	Buy	+1,000	New	+$253K	﹤0.01%	2179

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Two Sigma Advisers's SWAV Position: Q1 2023 in Review

Two Sigma Advisers sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2023, closing a stake of 1,000 shares — an estimated $206K sold.

Two Sigma Advisers first reported a position in SWAV in Q4 2022 and held it in 1 quarter. The position peaked at $206K in Q4 2022. 381 funds tracked by Wall St. Rank hold SWAV as of Q1 2023.

Two Sigma Advisers reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Two Sigma Advisers sold 1,000 Shockwave Medical, Inc. Common Stock shares in Q1 2023, an estimated $206K.
Two Sigma Advisers first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Two Sigma Advisers's Shockwave Medical, Inc. Common Stock position peaked at $206K in Q4 2022.
381 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2023.

Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.